Long-term outcome of EUS-guided ethanol injection therapy for patients with pancreatic neuroendocrine neoplasm

Long-term outcome of EUS-guided ethanol injection therapy for patients with pancreatic neuroendocrine neoplasm - Long-term outcome of ethanol injection therapy for patients with pancreatic neuroendocrine neoplasm

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044094

Enrollment

Registered

2021-06-10

Start date

2021-06-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic neuroendocrine neoplasm

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who participated and treated in "EUS-guided ethanol injection therapy for pancreatic neuroendocrine tumors: multicenter prospective intervention study" . 2. Patients who can obtain written informed consent to participate in the research.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
RFS	—

Secondary

Measure	Time frame
OS PFS Incidence and/or exacerbation of DM Procedure related late adverse events Treatment for patients with relapse or exacerbation of tumor	—

Countries

Japan

Contacts

Public ContactKazuyuki Matsumoto

Okayama University Hospital Gastroenterology

matsumoto.k@okayama-u.ac.jp086-235-7219

Outcome results